1. Careers

Your suggestion is on its way!

An email with a link to:


was emailed to:

Thanks for sharing About.com with others!

Military Medical Standards for Continued Service
Neurologic Disorders
More of this Feature
Medical Standards Menu
Join the Discussion
Visit Our Message Forum
Related Resources

Military Medical Resources
Submarine Duty Medical
Air Force Flight Physicals

The following medical conditions could result in initiation of a Medical Evaluation Board (MEB), and could result in medical discharge:

Amyotrophic lateral sclerosis.

Myelopathic muscular atrophy, including residuals of poliomyelitis.

Progressive muscular atrophy.

Chorea. Chronic and progressive.

Friedreich's ataxia.

Hepatolenticular degeneration.

Seizure disorder.

For Active Duty, MEB processing must be done within 90 calendar days of the first episode.

Seizures following omission of prescribed medication or ingestion of alcoholic beverages are not indicative of the controllability of the disorder.

Migraine. Manifested by frequent disabling attacks which last for several consecutive days, and are unrelieved by treatment.

Multiple sclerosis.

Myasthenia gravis

Transverse myelopathy.

Narcolepsy. When attacks are not controlled by medication.

Paralysis agitans.

Peripheral nerve conditions such as:

Neuralgia, when symptoms are severe, persistent, and do not respond to treatment.

Neuritis or paralysis due to peripheral nerve injury, when manifested by more than moderate, permanent functional


Other neurological conditions. Any other neurological condition, regardless of etiology, when after adequate treatment, there remain residuals, such as persistent severe headaches, weakness or paralysis of important muscle groups, deformity, incoordination, pain or sensory disturbance, disturbance of consciousness, speech, or mental defects, or personality changes of such a degree as to definitely interfere with the performance of duty.

Above Information Derived from Air Force Instruction 148-23

Subscribe to the Newsletter

See More About

©2016 About.com. All rights reserved.